Donoghue Forlines’s Teladoc Health TDOC Stock Holding History

Donoghue Forlines’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,953	Closed	-$1.52M	–	143
2020 Q2	$1.52M	Buy	+7,953	New	+$1.39M	0.4%	31

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Donoghue Forlines's TDOC Position: Q3 2020 in Review

Donoghue Forlines sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 7,953 shares — an estimated $1.52M sold.

Donoghue Forlines first reported a position in TDOC in Q2 2020 and held it in 1 quarter. The position peaked at $1.52M in Q2 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

Donoghue Forlines reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
Donoghue Forlines sold 7,953 Teladoc Health shares in Q3 2020, an estimated $1.52M.
Donoghue Forlines first reported a position in Teladoc Health in Q2 2020 and held it in 1 quarter.
Donoghue Forlines's Teladoc Health position peaked at $1.52M in Q2 2020.
743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Donoghue Forlines's 13F filing for Q3 2020, filed 16 Nov 2020.